Vincent Medical Holdings Limited

As of December 31, 2025, Vincent Medical Holdings Limited carries a market capitalization of 547.01M, placing it among publicly traded companies globally. Its enterprise value stands at 482.07M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Vincent Medical Holdings Limited's next confirmed earnings release is scheduled for March 24, 2027.

As of December 31, 2025, Vincent Medical Holdings Limited has 659.05M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Vincent Medical Holdings Limited maintains a current ratio of 1.96, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 23, 2026, Vincent Medical Holdings Limited's stock has declined approximately 18.02% over the past 52 weeks. The 50-day moving average sits at 0.69, while the 200-day moving average is 0.82.

As of December 31, 2025, Vincent Medical Holdings Limited holds 250.87M in cash and equivalents against 177.42M in total debt, resulting in a net debt position of -104.50M. Total book value stands at 664.65M, with working capital of 341.86M providing operational flexibility.